Case report reveals aggressive gallbladder SCC with β-hCG immunoreactivity, suggesting poor prognosis.
Purpose Gallbladder squamous cell carcinoma (SCC) is a rare subtype of gallbladder malignancy, comprising only 1–4% of cases. Ectopic expression of β-human chorionic gonadotropin (β-hCG) has been described in various epithelial cancers and is associated with aggressive behavior. We report the first known case of gallbladder SCC with diffuse β-hCG expression and markedly elevated serum β-hCG levels, aiming to explore its clinicopathological implications and potential as a prognostic biomarker. Methods We present the clinical, radiologic, surgical, and pathological findings of a patient with a large gallbladder mass. A literature review was conducted to contextualize our findings. Results The patient underwent open cholecystectomy with hepatic segment IVb/V resection. Final pathology revealed poorly differentiated SCC with acantholytic features and diffuse β-hCG immunoreactivity. Two metastatic lymph nodes were identified in the low hepatoduodenal nodal basin. Postoperative serum β-hCG was significantly elevated. Despite surgical resection, the patient experienced rapid disease recurrence and progression. Conclusion This case represents the first documented instance of β-hCG-expressing gallbladder SCC. Diffuse β-hCG expression may reflect a dedifferentiated and aggressive tumor phenotype associated with early metastasis and poor prognosis. Further studies are warranted to investigate the prognostic and biological significance of β-hCG in gallbladder SCC and its potential role as a biomarker.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: